CNR1 and schizophrenia: In support of the antipsychotic effect of CBD mediated by antagonism of the CB1R, the most important argument is that the acute administration of THC (an exogenous CB1 agonist) can transiently exacerbate psychosis in patients with schizophrenia [201] and induce transient psychotic-like symptoms in healthy volunteers [202,203].